Defence Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Sep '24 Sep 24, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Market Capitalization	24	34	128	73	245	-	Upgrade
Market Cap Growth	-73.58%	-73.58%	74.18%	-70.15%	-	-	Upgrade
Enterprise Value	25	35	126	72	239	-	Upgrade
Last Close Price	0.52	0.74	2.92	2.00	7.05	-	Upgrade
PE Ratio	-	-2.47	-17.12	-9.83	-65.58	-	Upgrade
PB Ratio	-9.40	-9.40	81.44	-188.95	44.71	-	Upgrade
P/FCF Ratio	-7.50	-7.50	-16.51	-12.12	-107.16	-	Upgrade
P/OCF Ratio	-7.86	-7.86	-16.66	-12.12	-107.16	-	Upgrade
EV/EBITDA Ratio	-2.75	-2.75	-19.49	-	-	-	Upgrade
EV/EBIT Ratio	-2.73	-2.73	-19.45	-9.85	-84.48	-	Upgrade
EV/FCF Ratio	-5.65	-7.74	-16.35	-11.85	-104.26	-	Upgrade
Debt / Equity Ratio	-0.49	-0.49	1.11	-	-	-	Upgrade
Debt / FCF Ratio	-0.39	-0.39	-0.23	-	-	-	Upgrade
Quick Ratio	0.04	0.04	13.35	0.48	45.19	38.59	Upgrade
Current Ratio	0.05	0.05	15.58	0.61	45.50	38.59	Upgrade
Return on Equity (ROE)	-	-	-1147.59%	-288.03%	-77.80%	-72.25%	Upgrade
Return on Assets (ROA)	-397.30%	-397.30%	-190.91%	-143.66%	-46.96%	-43.83%	Upgrade
Return on Capital (ROIC)	-1080.63%	-1080.63%	-277.57%	-178.30%	-48.05%	-45.16%	Upgrade
Earnings Yield	-56.84%	-39.15%	-5.30%	-10.03%	-1.17%	-	Upgrade
FCF Yield	-18.97%	-13.33%	-6.06%	-8.25%	-0.93%	-	Upgrade
Buyback Yield / Dilution	-12.54%	-12.54%	-9.93%	-35.65%	-2719.76%	-	Upgrade
Total Shareholder Return	-12.54%	-12.54%	-9.93%	-35.65%	-2719.76%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.